235 related articles for article (PubMed ID: 8242857)
21. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N'-nitro-N-nitrosoguanidine and promoted by mezerein.
Rehman I; Lowry DT; Adams C; Abdel-Fattah R; Holly A; Yuspa SH; Hennings H
Mol Carcinog; 2000 Apr; 27(4):298-307. PubMed ID: 10747294
[TBL] [Abstract][Full Text] [Related]
22. Diacylglycerol is an effector of the clonal expansion of cells containing activated Ha-ras genes.
Mills KJ; Reynolds SH; Smart RC
Carcinogenesis; 1993 Dec; 14(12):2645-8. PubMed ID: 8269640
[TBL] [Abstract][Full Text] [Related]
23. Cell-type-specific ras mutations but no microsatellite instability in chemically induced mouse skin tumors and transformed 3T3 cells.
Sasaki K; Bertrand O; Nakazawa H; Fitzgerald DJ; Mironov N; Yamasaki H
Cancer Res; 1995 Aug; 55(16):3513-6. PubMed ID: 7627957
[TBL] [Abstract][Full Text] [Related]
24. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression.
Brown K; Buchmann A; Balmain A
Proc Natl Acad Sci U S A; 1990 Jan; 87(2):538-42. PubMed ID: 2105486
[TBL] [Abstract][Full Text] [Related]
25. Low frequency of codon 61 Ha-ras mutations and lack of keratin 13 expression in 7,12-dimethylbenz[a]-anthracene-induced hamster skin tumors.
Robles AI; Gimenez-Conti IB; Roop D; Slaga TJ; Conti CJ
Mol Carcinog; 1993; 7(2):94-8. PubMed ID: 7681292
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of CREB function in mouse epidermis reduces papilloma formation.
Rozenberg J; Rishi V; Orosz A; Moitra J; Glick A; Vinson C
Mol Cancer Res; 2009 May; 7(5):654-64. PubMed ID: 19435810
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents.
Pelling JC; Fischer SM; Neades R; Strawhecker J; Schweickert L
Carcinogenesis; 1987 Oct; 8(10):1481-4. PubMed ID: 3115617
[TBL] [Abstract][Full Text] [Related]
28. Synergistic interaction between the non-phorbol ester-type promoter mirex and 12-O-tetradecanoylphorbol-13-acetate in mouse skin tumor promotion.
Meyer SA; Kim TW; Moser GJ; Monteiro-Riviere NA; Smart RC
Carcinogenesis; 1994 Jan; 15(1):47-52. PubMed ID: 8293547
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of mouse skin tumorigenesis by dexamethasone occurs through a Ha-ras-independent mechanism.
Strawhecker JM; Pelling JC
Carcinogenesis; 1992 Nov; 13(11):2075-80. PubMed ID: 1423878
[TBL] [Abstract][Full Text] [Related]
30. Methylation of the O6-methylguanine-DNA methyltransferase promoter suppresses expression in mouse skin tumors and varies with the tumor induction protocol.
Abdel-Fattah R; Glick A; Rehman I; Maiberger P; Hennings H
Int J Cancer; 2006 Feb; 118(3):527-31. PubMed ID: 16094607
[TBL] [Abstract][Full Text] [Related]
31. Characterization of skin tumor promotion by mirex: structure-activity relationships, sexual dimorphism and presence of Ha-ras mutation.
Moser GJ; Robinette CL; Smart RC
Carcinogenesis; 1993 Jun; 14(6):1155-60. PubMed ID: 8508502
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ras p21 membrane localization and modulation of protein kinase C isozyme expression during regression of chemical carcinogen-induced murine skin tumors by lovastatin.
Khan SG; Saxena R; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1995 Apr; 12(4):205-12. PubMed ID: 7727042
[TBL] [Abstract][Full Text] [Related]
33. Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.
Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR
Mol Carcinog; 1994 May; 10(1):15-22. PubMed ID: 8185825
[TBL] [Abstract][Full Text] [Related]
34. Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.
Chandramouli A; Shi J; Feng Y; Holubec H; Shanas RM; Bhattacharyya AK; Zheng W; Nelson MA
Carcinogenesis; 2007 Sep; 28(9):2028-35. PubMed ID: 17389615
[TBL] [Abstract][Full Text] [Related]
35. The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.
Chakravarti D; Venugopal D; Mailander PC; Meza JL; Higginbotham S; Cavalieri EL; Rogan EG
Mutat Res; 2008 Jan; 649(1-2):161-78. PubMed ID: 17931959
[TBL] [Abstract][Full Text] [Related]
36. A multihit, multistage model of chemical carcinogenesis.
Owens DM; Wei S; Smart RC
Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
[TBL] [Abstract][Full Text] [Related]
37. Induction of skin papillomas, carcinomas, and sarcomas in mice in which the connexin 43 gene is heterologously deleted.
Yamakage K; Omori Y; Zaidan-Dagli ML; Cros MP; Yamasaki H
J Invest Dermatol; 2000 Feb; 114(2):289-94. PubMed ID: 10651988
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period.
Nesnow S; Bergman H; Slaga TJ
Environ Health Perspect; 1986 Sep; 68():19-25. PubMed ID: 3780628
[TBL] [Abstract][Full Text] [Related]
39. Promoter independence as a feature of most skin papillomas in SENCAR mice.
Aldaz CM; Conti CJ; Chen A; Bianchi A; Walker SB; DiGiovanni J
Cancer Res; 1991 Feb; 51(3):1045-50. PubMed ID: 1899044
[TBL] [Abstract][Full Text] [Related]
40. Lack of effect of retinoic acid and fluocinolone acetonide on mirex tumor promotion indicates a novel mirex mechanism.
Kim TW; Smart RC
Carcinogenesis; 1995 Sep; 16(9):2199-204. PubMed ID: 7554075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
